Small Cap Feast
Small Cap Feast – 14 July 2020
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
What’s Cooking in the IPO Kitchen?
AEX Gold (TSXV:AEV) is intending to admit its shares to AIM alongside a £45m placing. The Company, led by CEO Eldur Ólafsson, has established the largest land package of gold assets in Greenland with a current portfolio of licences covering 3,356 square kilometres, in the two known gold belts in Southern Greenland, the Nanortalik and Tartoq gold belts. Nalunaq is a high-grade gold asset with an updated Inferred Mineral Resource covering 422,770 tonnes at 18.5 grams per tonne of gold, or 250,970 ounces of gold, which covers the area in and around the historical mine. Due July. Current mkt cap C$66.7m.
Netcall 39p £56.3m (NET.L)
The provider of Low-code and customer engagement solutions, today announces its trading update for the year ended 30 June 2020.
The Board anticipates full year revenue to be £25.1m corresponding to 10% growth (FY19: £22.9m) and adjusted EBITDA growth of approximately 29% to £4.4m (FY19: £3.4m), in line with market expectations.
Cloud annual contract value (ACV) increased 25% to £7.5m (FY19: £6.0m) contributing to a 7% growth in total ACV to £16.8m (FY19: £15.7m).
Mattioli Woods 715p £193m (MTW.L)
The specialist wealth management and employee benefits business, today issues the following trading update for the year ended 31 May 2020. The final results for the year will be announced on Tuesday, 2 September 2020.
- Growth in revenue and strong growth in adjusted EBITDA and adjusted PBT
- Improved margins following operational restructure pre COVID-19
- Mitigating actions taken to protect financial position in light of the COVID-19 pandemic
- Continued to deliver an uninterrupted service to clients
- Building capacity to do more for existing clients and future growth
- Total client assets of the Group and its associate3 of £9.3 billion at the year end
- Gross discretionary assets under management4 of £2.6 billion, with net inflows of over £200 million during the year
- Recent acquisitions integrating well
- Strong financial position, with £26.0 million of cash at year end
Elecosoft 78.5p £64.6m (ELCO.L)
Trading update for the six months ended 30 June 2020, based on unaudited management accounts for the period.
Unaudited revenues for the six months ended 30 June 2020 held up well and were lower than revenues for the same period last year by only 4 per cent.
Unaudited management accounts for the six months ended 30 June 2020 also showed that profits before tax increased by 23 per cent, compared with profit before tax in the same period last year and that adjusted profit before tax increased by 14 per cent.
Strong cashflow in the period ended 30 June 2020 also enabled Elecosoft to improve its net cash position from £1.1m at 31 December 2019 to £4.4m as at 30 June 2020.
The Board of Elecosoft expects to release Elecosoft’s interim results in late September and will announce the date in due course.
Inspecs Group 205p £145m (SPEC.L)
Inspecs Group plc, a designer, manufacturer and distributor of eyewear frames to independent and global retail chains, has completed the acquisition of the manufacturing operations of The Norville Group Ltd from the Administrator, BDO LLP, for a total cash consideration of £2.4m. The acquisition includes £1.2m of freehold property for Norville’s Gloucester site and the remainder for stock, plant, IP and contracts.
Norville is a long-established manufacturer of optically advanced spectacle lenses, supplying optical retailers with complete spectacles, including well-known brands, and is considered to have the most advanced portfolio of spectacle lenses in the UK. The manufacturing operations are undertaken primarily from the business’ headquarters in Gloucester, with smaller operations in Bolton, Seaham and Livingston. Inspecs intends to retain part of Norville’s management team and employees as part of the acquisition.
Norville’s management accounts for the year to 31-Dec-19 show unaudited revenue of £11.8m, loss before tax of £0.79m and EBITDA of £0.39m. The net book value of the assets acquired was £4.9m including the freehold property. The acquisition is being funded from the Group’s existing cash resources.
Thor Mining 0.38p £4.87m (THR.L)
Sale of the Spring Hill gold project royalty entitlement, subject to approval from the Australian government Foreign Investment Review Board (FIRB), to AIM quoted Trident Royalties Plc:
- Total consideration of A$1.0 million,
- Initial payment of A$400,000, comprising A$50,000 immediate payment, followed by A$350,000 on completion, including FIRB approval,
- First production milestone payment of A$300,000 upon cumulative sales reaching 25,000 ounces of gold,
- Second production milestone payment of A$300,000 upon cumulative sales reaching 50,000 ounces of gold.
EKF Diagnostics 47.5p £216m (EKF.L)
Trading update for the six months ended 30 June 2020 and confirmation that, since the 15 May 2020 update, it has received PrimeStore MTM sample collection device orders totalling $9.0m. This brings the current total of such orders for the three month period ending 30 September 2020 to $14.1m.
The current financial year has started very well, as reflected in the recent trading updates and upgraded market expectations. The over-performance, in terms of adjusted EBITDA growth, is largely due to high demand for the PrimeStore MTM Device which is used for safe COVID-19 sample collection and is manufactured under contract by EKF in the US and UK.
Previous guidance from the 15 May 2020 trading update set expectations of revenues of at least £25m and adjusted EBITDA £7.5m for the first half, and these have been comfortably exceeded. Revenues for the six months ended 30 June 2020 are £26.3m (H1 2019: £21.44m) and the Company expects to report adjusted EBITDA in the region of £9m (H1 2019: £5.58m).
Brand Architekts 107.4p £18.5m (BAR.L)
The personal care and beauty products group with its own portfolio of brands, announces an update on trading for the 52 weeks to 27 June 2020 and board succession.
Sales performance during the second half of the financial year (“FY”), which was inevitably impacted by the COVID-19 pandemic, was stronger than the Board had anticipated and communicated at the time of our last trading update in April. However, revenue generated in H2 2020 is still significantly below the comparative period last year.
Net sales for FY20 were £16.3m, which excludes sales from discontinued operations, a decline of 17% on the prior year. Sales in the first half were £10.6m, a decline of 15% when compared to H1 2019 (£12.5m). Sales in the second half of FY20 declined by 21%, with net sales of £5.7m (H2 2019: £7.2m).
RBG Holdings 77.2p £66.1m (RBGP.L)
The professional services group, which owns LionFish Litigation Finance (UK) Limited (“LionFish”) , has today launched ISLERO – a new generation of financing solutions for insolvency claims.
Available through the Group’s litigation finance arm LionFish, ISLERO is designed to answer the increasing calls of insolvency practitioners and solicitors for cheaper, faster and more flexible financing solutions than are currently available. Using the legal expertise and financial support of the Group, ISLERO will offer insolvency practitioners cheaper and more flexible pricing structures, including some interest rate-based alternatives.
Fast Forward Innovations 5.7p £9.2m (FFWD.L)
Notes the update from TSXV traded Globalive Technology Inc regarding FFWD’s investee company, Yooma Corp. in which it holds a 10.65% interest. Yooma has signed a binding letter of intent (the “LOI”) with Globalive to complete a reverse take-over pursuant to which Globalive will acquire all of the issued and outstanding securities of Yooma in exchange for common shares of Globalive. The Yooma Transaction remains subject to material conditions outlined below and is contemplated to complete contemporaneously with Globalive’s proposed acquisition of a CBD ingredient wholesaler, Socati Corp. ( https://socati.com/ ) . It is expected that FFWD’s former Chairman Lorne Abony will remain on the Board of the Enlarged Group following completion.
Arc Minerals 2.825p £27.6m (ARCM.L)
Arc’s two subsidiaries, Zamsort and Zaco, have signed a confidentiality and 6 month exclusivity agreement with a subsidiary of Anglo American in respect of its copper exploration licenses in Zambia.
During the exclusivity period, Anglo American will be permitted to conduct a technical review which, if satisfactory, may result in an extension of the exclusivity and the negotiation of a commercial transaction.
Arc will continue with its existing drilling programme during the period of the agreement.
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email firstname.lastname@example.org with “unsubscribe me”.